Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2b mice inhibits resistance to virus-induced demyelination

Xiaoqi Lin, M. Kariuki Njenga, Aaron J. Johnson, Kevin D. Pavelko, Chella S. David, Larry R Pease, Moses Rodriguez

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

We investigated the role of the immune system in protecting against virus-induced demyelination by generating lines of transgenic B10 (H-2b) congenic mice expressing three independent contiguous coding regions of the Theiler's murine encephalomyelitis virus (TMEV) under the control of a class I major histocompatibility complex (MHC) promoter. TMEV infection of normally resistant B10 mice results in virus clearance and development of inflammatory demyelination in the spinal cord. Transgenic expression of the viral capsid genes resulted in inactivation of virus-specific CD8+ T lymphocytes (class I MHC immune function) directed against the relevant peptides, but it did not affect production of virus capsid-specific antibodies or lymphocyte proliferation to the virus antigen (class II MHC immune functions). Following intracerebral infection with TMEV, all three lines of mice survived the acute encephalitis but transgenic mice expressing VP1 (or the cluster of virus capsid proteins [VP4, VP2, and VP3] mapping to the left of VP1 in the TMEV genome) developed virus persistence and subsequent demyelination in spinal cord white matter. Transgenic mice expressing noncapsid proteins mapping to the right of VP1 (2A, 2B, 2C, 3A, 3B, 3C, and 3D) cleared the virus and did not develop demyelination. These results are consistent with the hypothesis that virus capsid gene products of TMEV stimulate class I-restricted CD8+ T-cell immune responses, which are important for virus clearance and for protection against myelin destruction. Presented within the context of self-antigens, inactivation of these cells by ubiquitous expression of relevant virus capsid peptides partially inhibited resistance to virus-induced demyelination.

Original languageEnglish (US)
Pages (from-to)7799-7811
Number of pages13
JournalJournal of Virology
Volume76
Issue number15
DOIs
StatePublished - 2002

Fingerprint

Theilovirus
Demyelinating Diseases
Viruses
gene expression
viruses
mice
Genes
Capsid
capsid
genes
Major Histocompatibility Complex
major histocompatibility complex
genetically modified organisms
Transgenic Mice
spinal cord
Spinal Cord
inactivation
T-lymphocytes
Virus Inactivation
Congenic Mice

ASJC Scopus subject areas

  • Immunology

Cite this

Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2b mice inhibits resistance to virus-induced demyelination. / Lin, Xiaoqi; Njenga, M. Kariuki; Johnson, Aaron J.; Pavelko, Kevin D.; David, Chella S.; Pease, Larry R; Rodriguez, Moses.

In: Journal of Virology, Vol. 76, No. 15, 2002, p. 7799-7811.

Research output: Contribution to journalArticle

Lin, Xiaoqi ; Njenga, M. Kariuki ; Johnson, Aaron J. ; Pavelko, Kevin D. ; David, Chella S. ; Pease, Larry R ; Rodriguez, Moses. / Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2b mice inhibits resistance to virus-induced demyelination. In: Journal of Virology. 2002 ; Vol. 76, No. 15. pp. 7799-7811.
@article{a275ef052e6c481dbc6dbde9c6e56e05,
title = "Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2b mice inhibits resistance to virus-induced demyelination",
abstract = "We investigated the role of the immune system in protecting against virus-induced demyelination by generating lines of transgenic B10 (H-2b) congenic mice expressing three independent contiguous coding regions of the Theiler's murine encephalomyelitis virus (TMEV) under the control of a class I major histocompatibility complex (MHC) promoter. TMEV infection of normally resistant B10 mice results in virus clearance and development of inflammatory demyelination in the spinal cord. Transgenic expression of the viral capsid genes resulted in inactivation of virus-specific CD8+ T lymphocytes (class I MHC immune function) directed against the relevant peptides, but it did not affect production of virus capsid-specific antibodies or lymphocyte proliferation to the virus antigen (class II MHC immune functions). Following intracerebral infection with TMEV, all three lines of mice survived the acute encephalitis but transgenic mice expressing VP1 (or the cluster of virus capsid proteins [VP4, VP2, and VP3] mapping to the left of VP1 in the TMEV genome) developed virus persistence and subsequent demyelination in spinal cord white matter. Transgenic mice expressing noncapsid proteins mapping to the right of VP1 (2A, 2B, 2C, 3A, 3B, 3C, and 3D) cleared the virus and did not develop demyelination. These results are consistent with the hypothesis that virus capsid gene products of TMEV stimulate class I-restricted CD8+ T-cell immune responses, which are important for virus clearance and for protection against myelin destruction. Presented within the context of self-antigens, inactivation of these cells by ubiquitous expression of relevant virus capsid peptides partially inhibited resistance to virus-induced demyelination.",
author = "Xiaoqi Lin and Njenga, {M. Kariuki} and Johnson, {Aaron J.} and Pavelko, {Kevin D.} and David, {Chella S.} and Pease, {Larry R} and Moses Rodriguez",
year = "2002",
doi = "10.1128/JVI.76.15.7799-7811.2002",
language = "English (US)",
volume = "76",
pages = "7799--7811",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "15",

}

TY - JOUR

T1 - Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2b mice inhibits resistance to virus-induced demyelination

AU - Lin, Xiaoqi

AU - Njenga, M. Kariuki

AU - Johnson, Aaron J.

AU - Pavelko, Kevin D.

AU - David, Chella S.

AU - Pease, Larry R

AU - Rodriguez, Moses

PY - 2002

Y1 - 2002

N2 - We investigated the role of the immune system in protecting against virus-induced demyelination by generating lines of transgenic B10 (H-2b) congenic mice expressing three independent contiguous coding regions of the Theiler's murine encephalomyelitis virus (TMEV) under the control of a class I major histocompatibility complex (MHC) promoter. TMEV infection of normally resistant B10 mice results in virus clearance and development of inflammatory demyelination in the spinal cord. Transgenic expression of the viral capsid genes resulted in inactivation of virus-specific CD8+ T lymphocytes (class I MHC immune function) directed against the relevant peptides, but it did not affect production of virus capsid-specific antibodies or lymphocyte proliferation to the virus antigen (class II MHC immune functions). Following intracerebral infection with TMEV, all three lines of mice survived the acute encephalitis but transgenic mice expressing VP1 (or the cluster of virus capsid proteins [VP4, VP2, and VP3] mapping to the left of VP1 in the TMEV genome) developed virus persistence and subsequent demyelination in spinal cord white matter. Transgenic mice expressing noncapsid proteins mapping to the right of VP1 (2A, 2B, 2C, 3A, 3B, 3C, and 3D) cleared the virus and did not develop demyelination. These results are consistent with the hypothesis that virus capsid gene products of TMEV stimulate class I-restricted CD8+ T-cell immune responses, which are important for virus clearance and for protection against myelin destruction. Presented within the context of self-antigens, inactivation of these cells by ubiquitous expression of relevant virus capsid peptides partially inhibited resistance to virus-induced demyelination.

AB - We investigated the role of the immune system in protecting against virus-induced demyelination by generating lines of transgenic B10 (H-2b) congenic mice expressing three independent contiguous coding regions of the Theiler's murine encephalomyelitis virus (TMEV) under the control of a class I major histocompatibility complex (MHC) promoter. TMEV infection of normally resistant B10 mice results in virus clearance and development of inflammatory demyelination in the spinal cord. Transgenic expression of the viral capsid genes resulted in inactivation of virus-specific CD8+ T lymphocytes (class I MHC immune function) directed against the relevant peptides, but it did not affect production of virus capsid-specific antibodies or lymphocyte proliferation to the virus antigen (class II MHC immune functions). Following intracerebral infection with TMEV, all three lines of mice survived the acute encephalitis but transgenic mice expressing VP1 (or the cluster of virus capsid proteins [VP4, VP2, and VP3] mapping to the left of VP1 in the TMEV genome) developed virus persistence and subsequent demyelination in spinal cord white matter. Transgenic mice expressing noncapsid proteins mapping to the right of VP1 (2A, 2B, 2C, 3A, 3B, 3C, and 3D) cleared the virus and did not develop demyelination. These results are consistent with the hypothesis that virus capsid gene products of TMEV stimulate class I-restricted CD8+ T-cell immune responses, which are important for virus clearance and for protection against myelin destruction. Presented within the context of self-antigens, inactivation of these cells by ubiquitous expression of relevant virus capsid peptides partially inhibited resistance to virus-induced demyelination.

UR - http://www.scopus.com/inward/record.url?scp=0036310249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036310249&partnerID=8YFLogxK

U2 - 10.1128/JVI.76.15.7799-7811.2002

DO - 10.1128/JVI.76.15.7799-7811.2002

M3 - Article

C2 - 12097592

AN - SCOPUS:0036310249

VL - 76

SP - 7799

EP - 7811

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 15

ER -